On January 11, the Centers for Medicare and Medicaid Services (CMS) announced its much-anticipated coverage proposal for monoclonal antibody treatments that target amyloid for the treatment of Alzheimer’s disease. According to the proposed policy, this class of drugs, which includes aducanumab, also known by the brand name Aduhelm, would be covered for people with Medicare only if they are enrolled in qualifying clinical trials. Dr. Jason Karlawish joins the podcast to discuss the recent proposal, share his reaction to the decision, and tell us how this coverage policy could impact the development of other Alzheimer’s disease treatments in the future.
Guest: Jason Karlawish, MD, co-director, Penn Memory Center, professor of medicine, medical ethics and health policy, and neurology, University of Pennsylvania
Episode Topics1:48 What’s the difference between the FDA and Centers for Medicare and Medicaid Services?
3:58 What is the purpose of sharing a proposal and allowing public comment after? Is it possible the proposal could change?
9:09 What are your key takeaways from the CMS proposal?
11:58 Who’s being charged the cost of the treatment if it is part of a clinical trial?
18:33 What does this decision, with its focus on research often occurring in major urban medical centers, mean for equity and access?
26:27 What is the future of Alzheimer’s disease research after the CMS decision?
Show NotesRead the Center for Medicare and Medicaid Services’s press release about the proposed coverage policy, view submitted public comments about the decision, and submit your own comment.
Learn more about Dr. Jason Karlawish’s work and writing at his website.
Listen to our four-part episode series with Dr. Jason Karlawish about his book, The Problem of Alzheimer’s, on our website (episode 1, episode 2, episode 3, episode 4).
National Priorities for Dementia and Health Disparities Research
Alzheimer's Disease Risk Is High in People with Down Syndrome
Identifying and Managing Dementia in the Hospital Setting
A Look Inside a Brain with Alzheimer’s Disease
The Potential for Predicting Alzheimer’s Disease Through a Blood Test
What It Takes to Become a Dementia Friendly Hospital
How Biomarkers and Brain Imaging Are Used to Detect Early Stages of Alzheimer's Disease
Identification and Treatment of Swallowing Disorders in Older Adults
Support After Diagnosis: Dementia Care Specialists and Dementia Friendly Communities
New Study Looks at Fish Oil for Alzheimer’s Disease Prevention in Veterans
Obtaining a Memory Assessment and the Role of a Neuropsychologist in Memory Care
Caregiver Strategies for Overcoming Communication and Behavior Changes Due to Dementia
Holiday Thank You
The Effects of Hormone Replacement Therapy on Alzheimer’s Disease
Connecting the Gut Microbiome to Alzheimer’s Disease
The Importance of Sleep for a Healthy Life
Early Diagnosis Key to Alzheimer's Disease Treatment
MIND Diet for Healthy Brain Aging
What Is the Wisconsin ADRC?
Connecting Lifetime Stress to Brain Health
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Life in the A-Zone
Caregiver Storyteller - About Alzheimer’s and Dementia Caregiving
The Life, Love, and Alzheimer’s Podcast
Fading Memories: Alzheimer’s/Dementia Caregiver Support
Alzheimer’s Speaks